HAGE in triple negative breast cancer (TNBC) is a novel prognostic, predictive and actionable biomarker: a transcriptomic and protein expression analysis

Abdel-Fatah, T.M.A., McArdle, S.E. ORCID: 0000-0001-6929-9782, Agarwal, D., Moseley, P.M., Green, A.R., Ball, G.R. ORCID: 0000-0001-5828-7129, Pockley, A.G. ORCID: 0000-0001-9593-6431, Ellis, I.O., Rees, R.C. and Chan, S.Y.T., 2016. HAGE in triple negative breast cancer (TNBC) is a novel prognostic, predictive and actionable biomarker: a transcriptomic and protein expression analysis. Clinical Cancer Research, 22 (4), pp. 905-914. ISSN 1078-0432

Full text not available from this repository.
Item Type: Journal article
Publication Title: Clinical Cancer Research
Creators: Abdel-Fatah, T.M.A., McArdle, S.E., Agarwal, D., Moseley, P.M., Green, A.R., Ball, G.R., Pockley, A.G., Ellis, I.O., Rees, R.C. and Chan, S.Y.T.
Publisher: American Association for Cancer Research
Place of Publication: Philadelphia, PA, USA
Date: February 2016
Volume: 22
Number: 4
ISSN: 1078-0432
Identifiers:
NumberType
10.1158/1078-0432.CCR-15-0610DOI
405930Other
Divisions: Schools > School of Science and Technology
Record created by: EPrints Services
Date Added: 09 Oct 2015 09:47
Last Modified: 20 Jan 2021 13:54
URI: http://irep.ntu.ac.uk/id/eprint/2754

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year